- Home
- ELMD vs PRQR Comparison
ELMD vs PRQR Comparison
Compare ELMD & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | PRQR |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.0M | 250.7M |
| IPO Year | 2010 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ELMD | PRQR |
|---|---|---|
| Price | $29.64 | $2.46 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $36.00 | $8.14 |
| AVG Volume (30 Days) | 54.0K | ★ 558.5K |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.89 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | ★ $66,218,999.00 | $18,859,556.00 |
| Revenue This Year | $14.63 | N/A |
| Revenue Next Year | $11.54 | N/A |
| P/E Ratio | $31.75 | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $17.73 | $1.07 |
| 52 Week High | $35.56 | $3.46 |
Technical Indicators
Market Signals| Indicator | ELMD | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 71.55 | 58.54 |
| Support Level | $28.82 | $2.15 |
| Resistance Level | $30.34 | $2.42 |
| Average True Range (ATR) | 1.07 | 0.19 |
| MACD | 0.22 | 0.05 |
| Stochastic Oscillator | 81.49 | 96.46 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.